Medical Necessity Letter (Specialty Laboratory Testing)

[Practice or Health System Name, Department]
[Street Address]
[City, State ZIP]
Phone: [Practice phone]  |  Fax: [Practice fax]

Ordering Clinician: [Clinician full name], [Credentials]  |  NPI: [NPI]

Date: [Date of letter]

To: [Payer name], [Plan type]
ATTN: [Prior Authorization / Medical Review / Appeals]
[Utilization Management Department or Medical Director name] (Include only if known)
[Payer fax or mailing address]

Re:

Patient: [Patient full name]  |  DOB: [MM/DD/YYYY]

Member/Subscriber ID: [Member ID] (If unavailable: "Member ID: not available at time of submission.")

Group Number: [Group number] (Omit if not provided)

Claim Number: [Claim number]  |  Denial Reference: [Reference number] (Include only for appeals; omit otherwise)

Performing Laboratory: [Laboratory name]

Requested Test: [Exact test name and category]

Order Date: [MM/DD/YYYY]  |  Anticipated Date of Service: [MM/DD/YYYY or timeframe]

Request Type: [Coverage determination / Prior authorization / Coverage exception / Appeal]

Purpose Statement

I am requesting [coverage / prior authorization / a coverage exception / appeal of denial dated MM/DD/YYYY] for [exact test name] to evaluate [clinical indication or suspected condition] in [patient name]. Results will directly guide [treatment selection / therapy avoidance / surveillance intensity / diagnostic confirmation] as outlined below. (If requesting expedited review, add: "Expedited review requested due to [time-sensitive treatment decision / surgical planning / rapidly evolving clinical status].")

Patient Clinical Summary

[Problem-focused summary of presentation: onset, duration, severity, trajectory, functional impact, and risk features. Use hedged language for unconfirmed diagnoses: "concern for," "suspected," "consistent with."]

• Key symptoms and course: [Concise description supporting pre-test probability]
• Pertinent positives: [Findings increasing likelihood of suspected condition] (Include only if relevant)
• Pertinent negatives: [Findings narrowing the differential] (Include only if relevant)
• Functional impact: [Work, ADLs, quality of life, safety risks] (Include only if relevant)
• Risk features: [Red flags, comorbidities, severity markers]
• Relevant history: [Medical/surgical history directly supporting testing indication]
• Medications: [Current/recent therapies; note drugs impacted by results] (Include only if relevant)
• Allergies/adverse reactions: [Relevant drug reactions] (Include only for pharmacogenomic indications)
• Family history: [Hereditary risk details] (Include only if directly relevant to indication; if unknown, state: "Family history: unavailable.")
• Social/exposure history: [Infectious/toxicologic exposures] (Include only if relevant)

Prior Evaluation and Management

(Include only items supporting why this test is medically necessary now and not redundant.)

• [MM/DD/YYYY]: [Laboratory/imaging/pathology/microbiology] — [Key findings]
• [MM/DD/YYYY]: [Specialty consultation] — [Pertinent assessment]
• [MM/DD/YYYY]: [Therapies attempted] — [Response, intolerance, adverse effects, or contraindications]
• [MM/DD/YYYY]: [Why continued empiric management without testing is suboptimal]
• [MM/DD/YYYY]: [Repeat/serial test justification: new clinical event, phenotype change, progression, inadequate prior specimen, or improved methodology] (Include only if requesting repeat testing)
• Outside results requested; not yet available. (Include only if applicable)

Test Requested

[Test commercial name]

[Brief description of what the test measures and why appropriate for this indication.]

• Order intent: [Diagnostic / Prognostic / Predictive / Monitoring]
• Specimen: [Specimen type and source]
• Performing laboratory: [Lab name and location]
• Expected TAT: [Turnaround time] (Include only if clinically relevant)
• CPT/HCPCS codes: [Codes] (Include only if known; do not estimate)

(Add additional subsections for each additional test requested, each with separate justification.)

Medical Necessity Rationale

• Clinical question: [Exact decision dependent on results: determine etiology, confirm diagnosis, select or avoid specific therapy, guide surveillance, stratify risk]
• Why this test and why now: [Insufficiency of standard tests; why delay increases risk or cost; why this specific method/panel is required]
• Guidelines and policies: [Relevant specialty guidelines, consensus statements, or payer policy by organization and year]
• Coverage criteria mapping:
  • Criterion: [Policy criterion #1]
    Patient evidence: [Specific findings/dates satisfying criterion]
  • Criterion: [Policy criterion #2]
    Patient evidence: [Documentation satisfying criterion]
  • Criterion: [Policy criterion #3]
    Patient evidence: [Documentation satisfying criterion]
  • (Add or remove criteria to match applicable policy.)
• Alternatives considered: [Alternatives and why inadequate, inappropriate, or already performed]

How Results Will Change Management

• Positive / pathogenic / detected / abnormal: [Specific actions: targeted therapy initiation or selection, dose adjustment, therapy avoidance, referral, procedural changes, surveillance interventions]
• Negative / not detected / normal: [What will be ruled out, alternate pathway, testing or procedures avoided, de-escalation plan]
• Indeterminate / VUS / inconclusive: [Clarifying steps: segregation studies, repeat sampling, orthogonal confirmation, phenotype-driven follow-up, multidisciplinary review]
• Serious risks avoided: [Adverse event risk reduction or invasive procedure avoidance enabled by testing] (Include only if applicable)

Risks of Not Performing the Test

(Include this section only when genuine urgency exists or when it materially strengthens the case; otherwise omit entirely.)

• Clinical risks: [Delayed diagnosis, disease progression, avoidable complications]
• Therapeutic timing constraints: [Treatment start date, surgical scheduling, narrow therapeutic window]
• System risks: [Repeat hospitalizations, duplicative testing, higher downstream costs]

Supporting Documentation

• [Recent clinic notes: dates]
• [Prior laboratory/imaging/pathology results: test names and dates]
• [Specialty consult notes: dates]
• [Guideline excerpts or references]
• [Payer coverage policy excerpt] (Include if applicable)
• [Denial letter and EOB] (Include only for appeals)
• (If attachments unavailable, state what is missing and why.)

Closing

I am available for peer-to-peer discussion at [direct phone number] during [best days/times and time zone]. Please contact me if additional information is needed.

The contents of this letter are consistent with and supported by the patient's medical record.

Sincerely,

[Signature]

[Clinician printed name], [Credentials]  |  NPI: [NPI]

Date: [MM/DD/YYYY]